FindTrial
Sign In

Difference between drugs in critically ill patient with enteral feed intolerance.

Comparison of enteral erythromycin plus intravenous Metoclopramide versus entral erythromycin alone in critically ill patient with enteral feed intolerance - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062858
Enrollment
60
Registered
2024-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

Intervention1: Erythromycin plus metacloperamide: Tablet erythromycin will be given in the dose of 250mg 6 hourly and injection metacloperamide in dose of 10mg 8 hourly to patients with gastric feed i

Sponsors

Eras Lucknow medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Critically ill patients admitted in ICU who had enteral feed intolerence. Patients of either sex Patients of age group 18-75 year

Exclusion criteria

Exclusion criteria: Patients with allergy to study drugs. Treatment with any prokinetics drugs 24 h before participating in the study. Hemodynamic instability or presence of cardarrhythmia or prolonged QT interval .

Design outcomes

Primary

MeasureTime frame
PRIMARY OBJECTIVES: The rate of successful feeding at 48 hours after randomization. Timepoint: 48 hours.—

Secondary

MeasureTime frame
Icu length of stay Hospital length of stay Timepoint: Icu length of stay Hospital length of stay—

Countries

India

Contacts

Public ContactDr Krishnapratap mall

Era Medical college and hospital Lucknow

Dr_mall_79@yahoo.com.in9140283488

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026